Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL1025917 | 1.00 | MEN1 (0.40) | MEN1KMT2A | |
| Fluoride SCHEMBL1807885 | 0.96 | MEN1 (0.38) | MEN1KMT2A | |
| Fluoride SCHEMBL6424102 | 0.96 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL7097725 | 0.96 | — | — | |
| SCHEMBL5544690 | 0.96 | MEN1 (0.42) | MEN1KMT2A | |
| SCHEMBL1746 | 0.96 | — | — | |
| SCHEMBL319537 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL3210291 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL22577541 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| Iodide SCHEMBL115029 | 0.92 | MEN1 (0.40) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245089-A1 | PROCESSES FOR PREPARING TETRALIN COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| CN-116425129-B | Synthesis method of difluoro sulfimide | 昌德新材科技股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119208541-A | High specific energy battery adopting surface alloyed lithium cathode and preparation method thereof | 中国电子科技集团公司第十八研究所 | 2024-12-27 | — | — | CN | claimed |
| CN-112142821-B | Synthesis method and application of 9-fluoro steroid compound | 天津药业研究院股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-116425129-A | Synthesis method of difluoro sulfimide | 昌德新材科技股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-114478465-A | Preparation method of extrahepatic biliary tract toxin | 上海皓元生物医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114232009-A | Bimetallic MOF derived catalyst and preparation method and application thereof | 深圳信息职业技术学院 | 2022-03-25 | — | — | CN | claimed |
| CN-114220979-A | Catalyst carrier, preparation method thereof, catalyst and fuel cell | 深圳信息职业技术学院 | 2022-03-22 | — | — | CN | claimed |
| CN-112142821-A | Synthesis method and application of 9-fluoro steroid compound | 天津药业研究院股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-110373719-B | High-selectivity polysilicon etching solution and preparation method thereof | 湖北兴福电子材料有限公司 | 2020-12-15 | — | — | CN | claimed |
| US-9487470-B2 | 4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2016-11-08 | — | — | US | claimed |
| US-20150119458-A1 | 4-((SUBSTITUTED PHENYL) DIFLUOROMETHYL) PHENOXY CARBOXYLIC ACID DERIVATIVE, AND PREPARATION METHOD AND USES THEREOF | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2015-04-30 | — | — | US | claimed |
| EP-2842931-A1 | 4-((SUBSTITUTED PHENYL) DIFLUOROMETHYL) PHENOXY CARBOXYLIC ACID DERIVATIVE, AND PREPARATION METHOD AND USES THEREOF | Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) | 2015-03-04 | — | — | EP | claimed |
| CN-117246982-B | Lithium bis (fluorosulfonyl) imide and method for purifying lithium bis (fluorosulfonyl) imide | Shidai Sikang New Material Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| WO-2025245089-A1 | PROCESSES FOR PREPARING TETRALIN COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| CN-116425129-B | Synthesis method of difluoro sulfimide | 昌德新材科技股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-0937078-B1 | TRICYCLIC CARBAPENEM COMPOUNDS | GLAXOSMITHKLINE SPA (IT) | 2003-02-12 | — | — | EP | disclosed |
| US-20010047094-A1 | Tricyclic carbapenem compounds | GLAXO WELLCOME SPA | 2001-11-29 | — | — | US | disclosed |
| EP-0021331-B1 | PROCESS FOR PRODUCING SULFUR TETRAFLUORIDE | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-05-26 | — | — | EP | disclosed |
| EP-0021331-A1 | Process for producing sulfur tetrafluoride | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119458-A1 | 4-((SUBSTITUTED PHENYL) DIFLUOROMETHYL) PHENOXY CARBOXYLIC ACID DERIVATIVE, AND PREPARATION METHOD AND USES THEREOF | PPARA, PPARG, PPARD | MEN1 4866/4885KMT2A 2134/4885 |
| US-20010047094-A1 | Tricyclic carbapenem compounds | OXA1L, GNE, MGAM | MEN1 2910/4885KMT2A 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.